Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT

Mersana Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.19M -171.67M -204.21M -170.06M
Depreciation & Amortization
1.63M 1.52M 927K 855K
Stock-Based Compensation
16.46M 21.14M 21.52M 18.41M
Other Working Capital
-27.88M -42.68M 162.15M 9.6M
Other Non-Cash Items
-496K -1.1M -699K 723K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-30.74M -18.76M 133.1M 10.09M
Operating Cash Flow
-82.34M -168.88M -49.36M -139.99M
Capital Expenditures
-132K -2.17M -2.2M -648K
Cash Acquisitions
n/a n/a 150.52M n/a
Purchase of Investments
-133.43M -155.92M -247.52M n/a
Sales Maturities Of Investments
145M 277.97M 97M n/a
Other Investing Acitivies
n/a n/a -150.52M n/a
Investing Cash Flow
11.44M 119.88M -152.72M -648K
Debt Repayment
-2.23M -262K -272K 18.34M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
542K 1.4M 2.4M 2.22M
Financial Cash Flow
4.09M 94.67M 153.02M 63.65M
Net Cash Flow
-66.81M 45.68M -49.06M -76.99M
Free Cash Flow
-82.47M -171.05M -51.56M -140.64M